A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.

about

The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation.

P2860

Q47137383-559ADDBA-DC46-435F-A0F3-78B37605A0FE

P2860

A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.

Item

http://www.wikidata.org/entity/Q47637390

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

A phase I clinical trial of th ...... pharmacodynamics of warfarin.

@en

A phase I clinical trial of th ...... pharmacodynamics of warfarin.

@nl

type

Item

label

A phase I clinical trial of th ...... pharmacodynamics of warfarin.

@en

A phase I clinical trial of th ...... pharmacodynamics of warfarin.

@nl

prefLabel

A phase I clinical trial of th ...... pharmacodynamics of warfarin.

@en

A phase I clinical trial of th ...... pharmacodynamics of warfarin.

@nl

P1476

A phase I clinical trial of th ...... d pharmacodynamics of warfarin

@en

P2093

Erin B Bailey

http://www.w3.org/2001/XMLSchema#string

Gajanan Bhat

http://www.w3.org/2001/XMLSchema#string

Guru Reddy

http://www.w3.org/2001/XMLSchema#string

Hanna Bailey

http://www.w3.org/2001/XMLSchema#string

Neeraj Agarwal

http://www.w3.org/2001/XMLSchema#string

Sumati Gupta

http://www.w3.org/2001/XMLSchema#string

Sunil Sharma

http://www.w3.org/2001/XMLSchema#string

Theresa L Werner

http://www.w3.org/2001/XMLSchema#string

P2860

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.

Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.

Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors.

Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.

Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling.

Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer.

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer

The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.

P2888

s00280-015-2934-1

P304

299-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-015-2934-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jordan P McPherson

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26719074

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.

about

P2860

P2860

A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921